References
- VFEND (voriconazole) injection, powder, lyophilized, for solution. Available from: http://dailymed.nlm.nih.gov/dailymed/lookup.cfm? setid = dac26bcd-7a59-401f-9f66-a0649767cece#section-6
- FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. [7-26-2013].
- Available from: http://www.fda.gov/Drugs/DrugSafety/ucm362415.htm
- Brüggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Clin Infect Dis 2009;48:1441–1458.
- Balian JD, Sukhova N, Harris JW, et al. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther 1995;57:662–669.
- Davies-Vorbrodt S, Ito JI, Tegtmeier BR, et al. Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Pharmacotherapy 2013;33:22–30.